Skip to content
Home/Companies/Healthcare/Polygon Therapeutics

Polygon Therapeutics

Healthcare·France·Active·2yr hold
Entry
2024
Hold
2yr
Status
Active

Who owns Polygon Therapeutics?

Polygon Therapeutics is currently owned by Audacia through Sorbonne Venture by Audacia (2020 vintage), since 2024.

Hand-verified · updated 2026-05-07

Audacia
Investor
Audacia
Sorbonne Venture by Audacia · 2020 · VC

Key facts

HQFrance
SectorHealthcare
StatusActive

More from Sorbonne Venture by Audacia

Other portfolio companies in the same fund.

Track Polygon Therapeutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Polygon Therapeutics?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Polygon Therapeutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue